• Je něco špatně v tomto záznamu ?

Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas

AA. Swanson, M. Michal, D. Xing, NK. Dashti, V. Židlík, EH. Cheek-Norgan, ME. Keeney, GL. Keeney, WR. Sukov, S. Gupta, MR. Nucci, JK. Schoolmeester

. 2024 ; 143 (-) : 24-32. [pub] 20231123

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007785

Leiomyosarcoma with adipocytic differentiation or lipoleiomyosarcoma is an uncommon sarcoma of the female genital tract with only a few individual reports in the literature. We therefore performed a morphologic, immunohistochemical, MDM2 gene amplification and RNA and DNA sequencing analysis of a series of gynecologic lipoleiomyosarcoma to better define the clinicopathologic spectrum. Six tumors from 6 patients were identified and classified as spindled lipoleiomyosarcoma (n = 2), mixed spindled and myxoid lipoleiomyosarcoma (n = 1), epithelioid lipoleiomyosarcoma with focal myxoid features (n = 1) and mixed spindled and epithelioid lipoleiomyosarcoma (n = 2). Patient age ranged from 41 to 64 years (mean: 49; median: 50). Primary location included uterine corpus (3), uterine corpus/cervix (2) and broad ligament (1). Tumor size ranged from 4.5 to 22 cm (mean: 11.2; median: 9.8). Four patients had metastasis at presentation or subsequently developed recurrent or distant disease. Patient status was known for 5: 2 dead of disease, 2 alive with disease and 1 alive without evidence of disease. Immunohistochemical expression of smooth muscle markers, ER, PR and WT-1 showed patterns similar to non-adipocytic gynecologic leiomyosarcomas. MDM2 amplification fluorescence in situ hybridization performed on 2 tumors was negative in 1 and equivocal in 1. Sequencing studies performed on 3 tumors found TP53 mutations in 3, with 1 tumor also having an ATRX alteration. No gene fusions were identified. Although lipoleiomyosarcomas have a diverse morphologic spectrum, our findings suggest the smooth muscle component shares morphologic and immunohistochemical features with female genital tract non-adipocytic leiomyosarcomas. Lipoleiomyosarcomas also have genetic alterations associated with non-adipocytic gynecologic leiomyosarcomas.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007785
003      
CZ-PrNML
005      
20240423160248.0
007      
ta
008      
240412e20231123xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.humpath.2023.11.008 $2 doi
035    __
$a (PubMed)38000678
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Swanson, Amy A $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
245    10
$a Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas / $c AA. Swanson, M. Michal, D. Xing, NK. Dashti, V. Židlík, EH. Cheek-Norgan, ME. Keeney, GL. Keeney, WR. Sukov, S. Gupta, MR. Nucci, JK. Schoolmeester
520    9_
$a Leiomyosarcoma with adipocytic differentiation or lipoleiomyosarcoma is an uncommon sarcoma of the female genital tract with only a few individual reports in the literature. We therefore performed a morphologic, immunohistochemical, MDM2 gene amplification and RNA and DNA sequencing analysis of a series of gynecologic lipoleiomyosarcoma to better define the clinicopathologic spectrum. Six tumors from 6 patients were identified and classified as spindled lipoleiomyosarcoma (n = 2), mixed spindled and myxoid lipoleiomyosarcoma (n = 1), epithelioid lipoleiomyosarcoma with focal myxoid features (n = 1) and mixed spindled and epithelioid lipoleiomyosarcoma (n = 2). Patient age ranged from 41 to 64 years (mean: 49; median: 50). Primary location included uterine corpus (3), uterine corpus/cervix (2) and broad ligament (1). Tumor size ranged from 4.5 to 22 cm (mean: 11.2; median: 9.8). Four patients had metastasis at presentation or subsequently developed recurrent or distant disease. Patient status was known for 5: 2 dead of disease, 2 alive with disease and 1 alive without evidence of disease. Immunohistochemical expression of smooth muscle markers, ER, PR and WT-1 showed patterns similar to non-adipocytic gynecologic leiomyosarcomas. MDM2 amplification fluorescence in situ hybridization performed on 2 tumors was negative in 1 and equivocal in 1. Sequencing studies performed on 3 tumors found TP53 mutations in 3, with 1 tumor also having an ATRX alteration. No gene fusions were identified. Although lipoleiomyosarcomas have a diverse morphologic spectrum, our findings suggest the smooth muscle component shares morphologic and immunohistochemical features with female genital tract non-adipocytic leiomyosarcomas. Lipoleiomyosarcomas also have genetic alterations associated with non-adipocytic gynecologic leiomyosarcomas.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    12
$a leiomyosarkom $x patologie $7 D007890
650    12
$a nádor z hladké svalové tkáně $x patologie $7 D018235
650    _2
$a hybridizace in situ fluorescenční $7 D017404
650    _2
$a nádorové biomarkery $x genetika $x analýza $7 D014408
650    _2
$a imunohistochemie $7 D007150
650    _2
$a ženské pohlavní orgány $x chemie $x patologie $7 D005836
650    _2
$a molekulární biologie $7 D008967
650    _2
$a protoonkogenní proteiny c-mdm2 $x genetika $7 D051736
655    _2
$a časopisecké články $7 D016428
700    1_
$a Michal, Michael $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; Bioptical Laboratory, Ltd., Pilsen, Czech Republic
700    1_
$a Xing, Deyin $u Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
700    1_
$a Dashti, Nooshin K $u Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
700    1_
$a Židlík, Vladimir $u Department of Pathology, University of Ostrava, Faculty of Medicine, Ostrava, Czech Republic
700    1_
$a Cheek-Norgan, E Heidi $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Keeney, Matthew E $u Department of Pathology, Northwestern Medicine Central DuPage Hospital, Winfield, Il, USA
700    1_
$a Keeney, Gary L $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Sukov, William R $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Gupta, Sounak $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
700    1_
$a Nucci, Marisa R $u Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA, USA
700    1_
$a Schoolmeester, J Kenneth $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA. Electronic address: schoolmeester.j@mayo.edu
773    0_
$w MED00002080 $t Human pathology $x 1532-8392 $g Roč. 143 (20231123), s. 24-32
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38000678 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160245 $b ABA008
999    __
$a ok $b bmc $g 2081649 $s 1217552
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 143 $c - $d 24-32 $e 20231123 $i 1532-8392 $m Human pathology $n Hum Pathol $x MED00002080
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace